Literature DB >> 7682764

The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.

S J Galli1, M Tsai, B K Wershil.   

Abstract

Many years ago, alert observers noticed among thousands of laboratory mice a few individuals that, unlike their littermates, exhibited areas of white spotting on their fur. No one could have predicted then that an effort to understand the basis for these abnormalities would ultimately contribute to the characterization of a receptor (c-kit) and a corresponding ligand (stem cell factor, SCF) that are critical not only to the migration and development of melanocytes, but also to hematopoiesis, gametogenesis, mast cell development, and, perhaps, development of the central nervous system. Nor could anyone have foretold then that this receptor and ligand would be shown to regulate the development of multiple distinct cellular lineages not only in mice, but also in humans and other primates, or that c-kit and its ligand would be found to influence the secretory function of cells bearing this receptor, as well as their development. Investigation of the effects of SCF on a single cell type, the mast cell, has produced the most complete picture of the spectrum of biological processes that can be regulated by interactions between c-kit and its ligand. This work shows that SCF critically regulates the migration and survival of mast cell precursors, promotes the proliferation of both immature and mature mast cells, enhances mast cell maturation, directly induces secretion of mast cell mediators, and can regulate the extent of mediator release in mast cells activated by IgE-dependent mechanisms. Indeed, SCF may well prove to be one of the most important of the factors influencing mast cell numbers, phenotype, and function in both health and disease. It now seems virtually certain that further studies of c-kit and SCF will produce important new insights into problems as diverse as the regulation of lineage commitment during normal hematopoiesis or the development and function of the central nervous system. And even though an effect on mast cell development was one of the last phenotypic abnormalities to be recognized in mice with mutations affecting the genes encoding c-kit or SCF, mast cells will continue to represent an important model system for analyzing the biology of c-kit and its ligand.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682764      PMCID: PMC1886888     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

Review 1.  Systemic mast cell disease. Analysis of 58 cases and literature review.

Authors:  W D Travis; C Y Li; E J Bergstralh; L T Yam; R G Swee
Journal:  Medicine (Baltimore)       Date:  1988-11       Impact factor: 1.889

2.  Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent.

Authors:  H Yano; B K Wershil; N Arizono; S J Galli
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

3.  Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice.

Authors:  K Nocka; S Majumder; B Chabot; P Ray; M Cervone; A Bernstein; P Besmer
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

4.  Multiple bidirectional alterations of phenotype and changes in proliferative potential during the in vitro and in vivo passage of clonal mast cell populations derived from mouse peritoneal mast cells.

Authors:  Y Kanakura; H Thompson; T Nakano; T Yamamura; H Asai; Y Kitamura; D D Metcalfe; S J Galli
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

5.  Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate.

Authors:  B K Wershil; T Murakami; S J Galli
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

6.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.

Authors:  B Chabot; D A Stephenson; V M Chapman; P Besmer; A Bernstein
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

7.  The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene.

Authors:  E N Geissler; M A Ryan; D E Housman
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

8.  Long-term in vitro culture of murine mast cells. III. Discrimination of mast cells growth factor and granulocyte-CSF.

Authors:  Y P Yung; M A Moore
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

9.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

10.  Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus.

Authors:  F H Qiu; P Ray; K Brown; P E Barker; S Jhanwar; F H Ruddle; P Besmer
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

View more
  72 in total

1.  Age-related changes in dermal mast cell prevalence in BALB/c mice: functional importance and correlation with dermal mast cell expression of Kit.

Authors:  P H Hart; M A Grimbaldeston; E K Hosszu; G J Swift; F P Noonan; J J Finlay-Jones
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

2.  Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents.

Authors:  Lindsey L Kennedy; Laura A Hargrove; Allyson B Graf; Taylor C Francis; Kyle M Hodges; Quy P Nguyen; Yoshi Ueno; John F Greene; Fanyin Meng; Victoria D Huynh; Heather L Francis
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

3.  Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1.

Authors:  C L Bone-Larson; C M Hogaboam; M L Steinhauser; S H Oliveira; N W Lukacs; R M Strieter; S L Kunkel
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  Constitutive expression of mouse mast cell protease-1 in normal BALB/c mice and its up-regulation during intestinal nematode infection.

Authors:  J M Wastling; C L Scudamore; E M Thornton; G F Newlands; H R Miller
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

5.  The development and distribution of the interstitial cells of Cajal in the intestine of the equine fetus and neonate.

Authors:  C Fintl; G T Pearson; S W Ricketts; I G Mayhew; N P H Hudson
Journal:  J Anat       Date:  2004-07       Impact factor: 2.610

Review 6.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

7.  Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on mast cell proliferation and A23187-induced histamine release, also accompanied by a decreased c-kit receptor.

Authors:  N Toyota; H Sakai; H Takahashi; Y Hashimoto; H Iizuka
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

8.  Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulation.

Authors:  Krisztina V Vukman; Tamás Visnovitz; Paul N Adams; Martin Metz; Marcus Maurer; Sandra M O'Neill
Journal:  Inflamm Res       Date:  2011-11-09       Impact factor: 4.575

Review 9.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

10.  Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.

Authors:  Emiliano Trias; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Mariángeles Kovacs; Ivan C Moura; Joseph S Beckman; Olivier Hermine; Luis Barbeito
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.